Oncogene - Table of Contents alert Volume 31 Issue 36

TABLE OF CONTENTS Volume 31, Issue 36 (September 2012) In this issue Review Original Articles Also new AOP Advertisement Target Cancer Metabolism (29-31 January 2013, Boston), is the only meeting where you can meet the leading companies working in this space, all focused on translating cancer metabolism into effective therapies. Learn from leading drug developers and apply their winning techniques to optimise your own pipeline. Secure your position in the field and source potential future collaborations to advance your cancer metabolism pipeline. www.cancer-metabolism-summit.com  Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement In this article recently published in Oncogenesis the authors propose that the MYCN-amplicon in the Kelly cells retains the ability to correctly interpret the environmental cues leading to downregulation of MYCN Reprogramming MYCN-amplified neuroblastoma cells R Carter et al ¦ doi:10.1038/oncsis.2012.24 Submit to Oncogenesis and contribute to this exciting journal!   Review Top Metabolic reprogramming of the tumor L M R Ferreira, A Hebrant and J E Dumont Oncogene 2012 31: 3999-4011; advance online publication, January 9, 2012; 10.1038/onc.2011.576 Abstract | Full Text Original Articles Top The insulin resistance Grb14 adaptor protein promotes thyroid cancer ret signaling and progression K Balogh, S L Asa, L Zheng, C Cassol, S Cheng and S Ezzat Oncogene 2012 31: 4012-4021; advance online publication, December 12, 2011; 10.1038/onc.2011.569 Abstract | Full Text Akt2 interacts with Snail1 in the E-cadherin promoter P Villagrasa, V M Díaz, R Viñas-Castells, S Peiró, B Del Valle-Pérez, N Dave, A Rodríguez-Asiain, J I Casal, J M Lizcano, M Duñach and A García de Herreros Oncogene 2012 31: 4022-4033; advance online publication, December 12, 2011; 10.1038/onc.2011.562 Abstract | Full Text Mcm2 deficiency results in short deletions allowing high resolution identification of genes contributing to lymphoblastic lymphoma M E Rusiniak, D Kunnev, A Freeland, G K Cady and S C Pruitt Oncogene 2012 31: 4034-4044; advance online publication, December 12, 2011; 10.1038/onc.2011.566 Abstract | Full Text microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cε J Datta, A Smith, J C Lang, M Islam, D Dutt, T N Teknos and Q Pan Oncogene 2012 31: 4045-4053; advance online publication, December 12, 2011; 10.1038/onc.2011.565 Abstract | Full Text EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway R Bonavia, M M Inda, S Vandenberg, S-Y Cheng, M Nagane, P Hadwiger, P Tan, D W Y Sah, W K Cavenee and F B Furnari Oncogene 2012 31: 4054-4066; advance online publication, December 5, 2011; 10.1038/onc.2011.563 Abstract | Full Text MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways W Qin, P Dong, C Ma, K Mitchelson, T Deng, L Zhang, Y Sun, X Feng, Y Ding, X Lu, J He, H Wen and J Cheng Oncogene 2012 31: 4067-4075; advance online publication, December 19, 2011; 10.1038/onc.2011.561 Abstract | Full Text Hypoxic activation of ATR and the suppression of the initiation of DNA replication through cdc6 degradation L Martin, M Rainey, C Santocanale and L B Gardner Oncogene 2012 31: 4076-4084; advance online publication, December 19, 2011; 10.1038/onc.2011.585 Abstract | Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.